Granahan Investment Management’s Aerie Pharmaceuticals AERI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-707,398	Closed	-$5.3M	–	183
2022 Q2	$5.3M	Sell	707,398 -881,546	-55%	-$6.21M	0.18%	115
2022 Q1	$14.5M	Buy	1,588,944 +350,061	+28%	+$2.7M	0.36%	74
2021 Q4	$8.7M	Sell	1,238,883 -155,387	-11%	-$1.63M	0.18%	120
2021 Q3	$15.9M	Buy	1,394,270 +6,299	+0.5%	+$92.1K	0.3%	86
2021 Q2	$22.2M	Buy	1,387,971 +228,662	+20%	+$3.92M	0.41%	58
2021 Q1	$20.7M	Buy	1,159,309 +825,546	+247%	+$14.3M	0.44%	53
2020 Q4	$4.51M	Buy	333,763 +232,514	+230%	+$2.81M	0.1%	137
2020 Q3	$1.19M	Sell	101,249 -64,245	-39%	-$782K	0.04%	166
2020 Q2	$2.44M	Buy	165,494 +47,216	+40%	+$698K	0.09%	144
2020 Q1	$1.6M	Sell	118,278 -128,301	-52%	-$2.43M	0.09%	148
2019 Q4	$5.96M	Sell	246,579 -6,363	-3%	-$132K	0.27%	84
2019 Q3	$4.86M	Buy	252,942 +202,257	+399%	+$4.63M	0.27%	88
2019 Q2	$1.5M	Buy	50,685 +16,009	+46%	+$617K	0.07%	156
2019 Q1	$1.65M	Sell	34,676 -22,747	-40%	-$1M	0.09%	160
2018 Q4	$2.07M	Buy	+57,423	New	+$2.69M	0.15%	130